Kotra Industries Berhad
0002.KL
Get informed when a big investor buys or sells
+ FollowMarket Cap$562.11M
Close$
$4.40
20.6% upside
Current Fair Value
20.6% upsideUndervalued by 20.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $562.11 Million |
|---|---|
| Enterprise Value | $551.49 Million |
| Dividend Yield | $0.22 (5.80%) |
| Earnings per Share | $0.27 |
| Beta | -0.1 |
| Outstanding Shares | 148,314,000 |
Return
| Return on Equity | 14.09% |
|---|---|
| Return on Assets | 10.86% |
| Return on Invested Capital | 16.54% |
Valuation & Multiples
| P/E Ratio | 13.84 |
|---|---|
| PEG | 55.09 |
| Price to Sales | 3.65 |
| Price to Book Ratio | 3.65 |
| Enterprise Value to Revenue | 2.37 |
| Enterprise Value to EBIT | 10.48 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
$64.80 M
Average shareholder expectationNext Earnings Call
Expected Date
December 1, 2026
EPS Estimate
$0.12
Average shareholder expectationRevenue Estimate
$64.80 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kotra Industries Berhad
720 employees
CEO: Teck Onn Piong Kotra Industries Berhad operates as an investment holding company, primarily involved in the development, manufacturing, and distribution of pharmaceutical and healthcare products throughout Malaysia. The firm provides a range of nutrace...